| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/25/2008 | US20080233592 Detecting the activity of and screening acceptor substrates, inhibitors, or activators of enzymes catalyzing group transfer reactions to facilitate the development of more selective and therapeutic drugs |
| 09/25/2008 | US20080233585 Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| 09/25/2008 | US20080233565 PKHDL1, a homolog of the autosomal recessive kidney disease gene |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233150 Respiratory syncytial virus-virus like particle (vlps) |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233140 Binding Dectin-1 on immune cells with anti-Dectin-1-specific antibodies; rAb proteins; antigen presentation and immune cell activation; vaccines |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233138 Coccidiosis Poultry Vaccine |
| 09/25/2008 | US20080233134 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/25/2008 | US20080233133 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 09/25/2008 | US20080233130 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; surface plasmon resonance; treating allergic hypersensitivity |
| 09/25/2008 | US20080233129 Ligand that has binding specificity for IL-4 and/or lL-13 |
| 09/25/2008 | US20080233126 G Proteins, Polynucleotides Encoding the Same and Utilization Thereof |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233123 Polypeptide from haemophilus influenzae |
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233115 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233112 Treatment of Diseases |
| 09/25/2008 | US20080233111 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection |
| 09/25/2008 | US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2008 | US20080233109 Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 09/25/2008 | US20080233108 Methods for detecting and inhibiting angiogenesis using antagonists |
| 09/25/2008 | US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | CA2682112A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | CA2681743A1 Stable antibody formulations |
| 09/25/2008 | CA2681341A1 Apoptotic anti-ige antibodies |
| 09/25/2008 | CA2681130A1 Novel human anti-r7v antibodies and uses thereof |
| 09/25/2008 | CA2680854A1 Treatment method using egfr antibodies and src inhibitors and related formulations |
| 09/25/2008 | CA2680368A1 A method of treating malignant mesothelioma |
| 09/25/2008 | CA2680111A1 Uses of monoclonal antibody 8h9 |
| 09/25/2008 | CA2680085A1 Hutnfr1 selective antagonists |
| 09/25/2008 | CA2656606A1 Anthrax carbohydrates,synthesis and uses thereof |
| 09/24/2008 | EP1972690A1 Desaturase antigen of mycobacterium tuberculosis |
| 09/24/2008 | EP1972689A2 A mutated immunoglobulin-binding protein |
| 09/24/2008 | EP1972640A1 Apoptosis inducing antibodies |
| 09/24/2008 | EP1972639A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 09/24/2008 | EP1972638A1 Remedies for juvenile chronic arthritis and related diseases |
| 09/24/2008 | EP1972637A1 huTNFR1 selective antagonists |
| 09/24/2008 | EP1972194A1 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 09/24/2008 | EP1971371A2 Cancer therapies and pharmaceutical compositions used therein |
| 09/24/2008 | EP1971367A2 Methods and compositions for needleless delivery of binding partners |
| 09/24/2008 | EP1971366A2 Human anti-il-23 antibodies, compositions, methods and uses |
| 09/24/2008 | EP1721162B1 Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a |
| 09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
| 09/24/2008 | EP1521771B1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 09/24/2008 | EP1385544B1 Humanized antibodies |
| 09/24/2008 | EP1368476B1 Rearranged squamous cell carcinoma antigen genes ii |
| 09/24/2008 | EP1084239B1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| 09/24/2008 | EP1029046B1 Wnt-1 inducible genes |
| 09/24/2008 | EP0979272B1 Strl33, a human fusion accessory factor associated with hiv infection |
| 09/24/2008 | CN101273134A Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes |
| 09/24/2008 | CN101273064A Anti-TrkB monoclonal antibodies and uses thereof |
| 09/24/2008 | CN101273063A A method for the production of a monoclonal antibody to CD20 for the treatment of b-cell lymphoma |
| 09/24/2008 | CN101273062A Antibodies against 25-hydroxyvitamin D |
| 09/24/2008 | CN101273061A Antibody formulations having optimized aggregation and fragmentation profiles |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |
| 09/24/2008 | CN101270162A Antihuman SCGN monoclone antibody, preparation, application and hybrid tumor cell strain |
| 09/24/2008 | CN101270161A Antihuman Reg4 monoclone antibody, preparation, application and hybrid tumor cell strain |
| 09/24/2008 | CN101270160A Monoclone antibody 1F1, uses thereof and hybridoma cell line BCSP31-1F1 excreting the antibody |
| 09/24/2008 | CN101269214A Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 09/23/2008 | US7427671 DNA sequence which code human platelet derived growth factor receptor proteins which preferentially binds to dimers of platelet derived growth factors with high receptivity |
| 09/23/2008 | US7427670 Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof |
| 09/23/2008 | US7427669 antibodies which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 09/23/2008 | US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 09/23/2008 | US7427667 monoclonal; humanized; fragments; labeled |
| 09/23/2008 | US7427666 Antibody directed against a ubiquitin-specific protease occurring in the brain |
| 09/23/2008 | US7427665 Chronic lymphocytic leukemia cell line |
| 09/23/2008 | US7427664 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 09/23/2008 | US7427661 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 09/23/2008 | US7427629 Immunostimulatory compositions and methods of stimulating an immune response |
| 09/23/2008 | US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation |
| 09/23/2008 | US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427471 Modified “S” antibodies |
| 09/23/2008 | US7427469 Method of treating cytomegalovirus with DC-SIGN blockers |
| 09/23/2008 | US7427468 Anti-TSG101 antibodies and their uses for treatment of viral infections |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | US7427401 Method of modulating leukemic cell and eosinphil activity with monoclonal antibodies |
| 09/23/2008 | US7427399 Antibodies and related molecules that bind to 161P2F10B proteins |
| 09/23/2008 | US7427392 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| 09/23/2008 | CA2445687C Compositions, methods and systems for the discovery of enediyne natural products |
| 09/23/2008 | CA2346797C Process for recovering heterologous polypeptides from bacterial cells |
| 09/23/2008 | CA2187283C Circularly permuted ligands and circularly permuted chimeric molecules |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/23/2008 | CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 09/18/2008 | WO2008112988A2 Apcdd1 inhibitors for treating, diagnosing or detecting cancer |
| 09/18/2008 | WO2008112840A2 Novel composition and methods for the treatment of immune related diseases |
| 09/18/2008 | WO2008112680A2 Global polyclonal antibodies, process for depleting commonly shared proteins by same, devices using same |
| 09/18/2008 | WO2008112514A1 He4 monoclonal antibodies and methods for their use |
| 09/18/2008 | WO2008112290A2 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 09/18/2008 | WO2008112201A2 Lysophosphatidic acid receptor targeting for lung disease |
| 09/18/2008 | WO2008112007A1 Immunoreactive glycoprotein gp19 of ehrlichia canis |